P04936 (POLG_HRV2) Human rhinovirus 2 (HRV-2)

Genome polyprotein UniProtKBInterProInteractive Modelling

2150 aa; Sequence (Fasta)

Available Structures

17 Experimental Structures

DescriptionPDB IDOligo-stateRangeLigands
HUMAN RHINOVIRUS SEROTYPE 2 (HRV2) Heteromer
3-850
DAO;
Assess
Human rhinovirus 2 bound to a concatamer of the VLDL receptor module V3 Heteromer
P98155;
3-850
DAO;CA;
Assess
Human Rhinovirus 2 bound to a fragment of its cellular receptor protein Heteromer
P98155;
3-850
DAO;CA;
Assess
Human rhinovirus 2 virion in situ Heteromer
23-850
Assess
Structure of HRV2 capsid complexed with antiviral compound BTA798 Heteromer
25-850
BT8;
Assess
Human rhinovirus 2 empty particle in situ Heteromer
81-850
Assess
X-ray structure of the HRV2 empty capsid (B-particle) Heteromer
83-850
Assess
X-ray structure of the HRV2 A particle uncoating intermediate Heteromer
83-850
Assess
FAB FRAGMENT (ANTIBODY 8F5) COMPLEXED WITH PEPTIDE FROM HUMAN RHINOVIRUS (SEROTYPE 2) VIRAL CAPSID … Heteromer
Q505N9; Q52L64;
225-239
Assess
Rhinovirus A2 2A protease in complex with zVAM.fmkhomo-2-mer851-989
S7N;ZN;S7Q;
Assess
Novel inhibitors of human rhinovirus 3C proteasemonomer1508-1687
6OY;
Assess
Novel inhibitors of human rhinovirus 3C proteasemonomer1508-1687
GOL;PG4;PGE;HOV;
Assess
Structure-based design and synthesis of macrocyclic human rhinovirus 3C protease inhibitorsmonomer1508-1687
D8K;SO4;DMS;GOL;
Assess
TYPE 2 RHINOVIRUS 3C PROTEASE WITH AG7088 INHIBITORmonomer1508-1687
AG7;
Assess
Structure-based design and synthesis of macrocyclic human rhinovirus 3C protease inhibitorsmonomer1508-1687
D8E;SO4;
Assess
Non-covalent inhibtors of rhinovirus 3C protease.monomer1508-1687
7L4;
Assess
2A CYSTEINE PROTEINASE FROM HUMAN RHINOVIRUS 2monomer851-989
ZN;
Assess

3 SWISS-MODEL models

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
2ijd.2.Bhomo-2-mer0.761508-2150
53.12
Assess
8r5x.1.Ahomo-4-mer0.672-832
50.61
Assess
8r5z.1.Ahomo-3-mer0.6581-832
50.61
Assess